OrthoPediatrics - Public Comps and Valuation Multiples

OrthoPediatrics Overview

About OrthoPediatrics

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.

Founded

2007

HQ

Employees

562

Website

orthopediatrics.com

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $215M

LTM EBITDA $10.6M

EV

$525M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

OrthoPediatrics Financials

OrthoPediatrics has a last 12-month revenue of $215M and a last 12-month EBITDA of $10.6M.

In the most recent fiscal year, OrthoPediatrics achieved revenue of $205M and an EBITDA of -$10.4M.

OrthoPediatrics expects next 12-month revenue of XXX and NTM EBITDA of XXX

See OrthoPediatrics valuation multiples based on analyst estimates

OrthoPediatrics P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$149M	$205M	XXX	XXX	XXX
Gross Profit	$90.7M	$111M	XXX	XXX	XXX
Gross Margin	61%	54%	XXX	XXX	XXX
EBITDA	-$8.4M	-$10.4M	XXX	XXX	XXX
EBITDA Margin	-6%	-5%	XXX	XXX	XXX
Net Profit	$1.3M	-$21.0M	XXX	XXX	XXX
Net Margin	1%	-10%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

OrthoPediatrics Stock Performance

As of April 15, 2025, OrthoPediatrics's stock price is $21.

OrthoPediatrics has current market cap of $521M, and EV of $525M.

See OrthoPediatrics trading valuation data

OrthoPediatrics Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$525M	$521M	XXX	XXX	XXX	XXX	$-1.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

OrthoPediatrics Valuation Multiples

As of April 15, 2025, OrthoPediatrics has market cap of $521M and EV of $525M.

OrthoPediatrics's trades at 2.4x LTM EV/Revenue multiple, and 49.5x LTM EBITDA.

Analysts estimate OrthoPediatrics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for OrthoPediatrics and 10K+ public comps

OrthoPediatrics Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$525M	XXX	XXX	XXX
EV/Revenue	2.6x	XXX	XXX	XXX
EV/EBITDA	-50.3x	XXX	XXX	XXX
P/E	-13.8x	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	-12.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get OrthoPediatrics Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

OrthoPediatrics Valuation Multiples

OrthoPediatrics's NTM/LTM revenue growth is 17%

OrthoPediatrics's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.3M for the same period.

Over next 12 months, OrthoPediatrics's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate OrthoPediatrics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for OrthoPediatrics and other 10K+ public comps

OrthoPediatrics Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	38%	XXX	XXX	XXX	XXX
EBITDA Margin	-5%	XXX	XXX	XXX	XXX
EBITDA Growth	25%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	12%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.4M	XXX	XXX	XXX	XXX
Opex per Employee	$0.3M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	31%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	50%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	5%	XXX	XXX	XXX	XXX
Opex to Revenue	87%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry